Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer

Y Zeng, RU Jin - Seminars in cancer biology, 2022 - Elsevier
cancer. In this review, we will examine the treatments for gastric cancer including up-to-date
molecularly targeted therapies … We will then review the molecular subtypes of gastric cancer

Pancreatic cancer: from molecular pathogenesis to targeted therapy

A Strimpakos, MW Saif, KN Syrigos - Cancer and Metastasis Reviews, 2008 - Springer
… alterations met in pancreatic cancer and the results of the florid preclinical and clinical
research with regards to the targeted therapy associated to these abnormalities. …

Molecular pathogenesis and targeted therapy of pancreatic cancer

S Tanaka - Annals of surgical oncology, 2016 - Springer
targeted therapy compared to other malignancies such as pancreatic neuroendocrine tumor.
This review summarizes the molecular pathogenesis of pancreatic cancer … “cancer stemness…

Thyroid cancer: pathogenesis and targeted therapy

DA Liebner, MH Shah - Therapeutic advances in …, 2011 - journals.sagepub.com
… radioiodine-resistant thyroid cancers have historically been … pathogenesis of the various
subtypes of thyroid cancer has led to increased interest in the development of targeted therapies

miRNAs role in cervical cancer pathogenesis and targeted therapy: Signaling pathways interplay

AS Doghish, MA Ali, SS Elyan, MA Elrebehy… - … -Research and Practice, 2023 - Elsevier
… with CC develop early metastases of the main tumor, resulting in poor therapeutic and
prognosis outcomes [7]. A molecule-targeted therapy for CC has evolved in recent years. …

Molecular pathogenesis and targeted therapy of hepatocellular carcinoma

L Zender, S Kubicka - Oncology Research and Treatment, 2008 - karger.com
… The most promising strategy for systemic treatment of HCC is targeted therapy. Successful
targeted therapy has to inhibit pathways which are necessary for tumor growth, even in the …

Signaling pathways in liver cancer: pathogenesis and targeted therapy

Y Xue, Y Ruan, Y Wang, P Xiao, J Xu - Molecular Biomedicine, 2024 - Springer
… the sole class of targeted therapeutics for liver cancer employed in … development of innovative
targeted strategies and the … utilization of targeted therapy in advanced liver cancer, with …

Molecular pathogenesis and targeted therapies for intrahepatic cholangiocarcinoma

A Moeini, D Sia, N Bardeesy, V Mazzaferro… - Clinical Cancer …, 2016 - AACR
Intrahepatic cholangiocarcinoma (iCCA) is a molecularly heterogeneous hepatobiliary
neoplasm with poor prognosis and limited therapeutic options. The incidence of this neoplasm is …

Basal cell carcinoma: from the molecular understanding of the pathogenesis to targeted therapy of progressive disease

D Göppner, M Leverkus - Journal of skin cancer, 2011 - Wiley Online Library
… This paper summarizes the current knowledge of clinical aspects and the molecular
pathogenesis of this form of skin cancer. Moreover, we discuss current and future therapies that are …

Targeted therapies: a new generation of cancer treatments

DE Gerber - American family physician, 2008 - aafp.org
Targeted therapies are generally better tolerated than traditional chemotherapy, but they …
Targeted therapy has raised new questions about the tailoring of cancer treatment to an …